Document Detail


Retrograde coronary venous contrast echocardiography: assessment of shunting and delineation of regional myocardium in the normal and ischemic canine heart.
MedLine Citation:
PMID:  6470339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coronary venous injections of sonicated Renografin-76 were performed in seven closed chest dogs during two-dimensional echocardiography to study the ability of this new technique to opacify regional myocardium before and after occlusion of the left anterior descending coronary artery. The balloon of a 4F double lumen catheter was inflated in the great cardiac vein for each contrast injection to prevent backflow through the coronary sinus into the right atrium. Retrograde injections before coronary artery occlusion generally resulted in patchy myocardial contrast uptake. Injections after coronary occlusion always resulted in confluent and transmural myocardial opacification which occupied 42.8 +/- 8.6% (range 26 to 54) (mean +/- standard deviation) of the myocardial circumference. Retrograde opacification always extended into adjacent myocardium beyond the ischemic zone, which was assessed in echocardiograms with antegrade contrast injections into the left main coronary artery and which measured 30 +/- 6.3% of the ventricular circumference. Shunting from the coronary venous system to cardiac chambers was evaluated in a parasternal four chamber view and was graded on a scale of 0 to 4+. Contrast appearance was equally intense in the right atrium and right ventricle (3.5 +/- 0.6+, range 2+ to 4+), less intense in the left ventricular cavity (1.5 +/- 0.6+, range 1+ to 3+) and absent in the left atrium. Postmortem anatomic validation with retrograde great cardiac vein injections of indocyanine green corroborated and in vivo contrast appearance in chambers. Retrograde coronary venous contrast echocardiography appears capable of providing in vivo information about the extent and location of myocardial zones that can be reached by retrograde infusions of therapeutic agents and about the ability of these agents to reach ischemic myocardium. In addition, this new method allows for in vivo evaluation of shunts between coronary veins and cardiac chambers, which may influence the efficacy of retrograde interventions.
Authors:
G Maurer; C Punzengruber; R V Haendchen; M A Torres; B Heublein; S Meerbaum; E Corday
Related Documents :
139829 - Abnormal myocardial fluid retention as an early manifestation of ischemic injury.
21821529 - Cardioprotection by ivabradine through heart rate reduction and beyond.
22668069 - Mitochondrial pathways, permeability transition pore and redox signaling in cardioprote...
2916409 - Carbon monoxide and lethal arrhythmias in conscious dogs with a healed myocardial infar...
2789099 - Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarcti...
21792669 - Carbon monoxide pollution impairs myocardial perfusion reserve: implication of coronary...
3511659 - Evaluation of the patient with congestive heart failure and ventricular arrhythmias.
8874949 - Acute myocardial infarction with dynamic outflow obstruction precipitated by intra-aort...
20429699 - The association between metabolic syndrome and infarct size in patients with acute myoc...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  4     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1984 Sep 
Date Detail:
Created Date:  1984-09-26     Completed Date:  1984-09-26     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  577-86     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Contrast Media
Coronary Circulation*
Coronary Disease / pathology*,  physiopathology
Diatrizoate / diagnostic use
Diatrizoate Meglumine / diagnostic use
Dogs
Drug Combinations / diagnostic use
Echocardiography / methods*
Heart Catheterization
Myocardium / pathology*
Grant Support
ID/Acronym/Agency:
HL 17651-10/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Drug Combinations; 117-96-4/Diatrizoate; 131-49-7/Diatrizoate Meglumine; 8064-12-8/urovision

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hemodynamic effects of intravenous amiodarone.
Next Document:  Contrast echocardiographic visualization of cough-induced right to left shunt through a patent foram...